Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
215654-55-0
165196-44-1
1022150-13-5
887579-10-4
23893-13-2 | Anhydroerythromycin A | AA007MT9 | MFCD00870758
1334500-04-7 | 3-(4-aminopyridin-2-yl)benzaldehyde HCl | AA007NCL | MFCD20231490
22717-42-6 | 3-Methyl-1-phenyl-4,5-dihydro-1h-pyrazole-5-thione | AA007NX2 | MFCD29991245
23935-66-2 | 2,4(1H,3H)-Pyrimidinedione, 5-(2-hydroxyethyl)-6-methyl- | AA007OCS | MFCD01316141
223127-49-9 | 4-(5-Nitropyridin-2-yl)benzoic acid | AA007OSY | MFCD05864816
1210-33-9 | 5-Chloro-10,11-dihydro-5h-dibenzo[a,d]cycloheptene | AA007P6Z | MFCD00003592
220957-39-1 | 5-Bromofuro[2,3-b]pyridine | AA007PJO | MFCD16628264
220464-68-6 | Methyl 3-(bromomethyl)-4-chlorobenzoate | AA007PWQ | MFCD16036858
121346-33-6 | N-(3,4-Dimethoxyphenethyl)-3-(4-((3-isopropyl-1-methyl-1H-indol-2-yl)sulfonyl)phenoxy)-N-methylpropan-1-amine oxalate | AA007QF2 | MFCD00919219
193359-51-2 | 4-[(2-Fluorophenyl)carbonyl]pyridine | AA007QWD | MFCD03411711
